Citation

McCoull W, Addie MS, Birch AM, Birtles S, Buckett LK, Butlin RJ, Bowker SS, Boyd S, Chapman S, Davies RD, Donald CS, Green CP, Jenner C, Kemmitt PD, Leach AG, Moody GC, Gutierrez PM, Newcombe NJ, Nowak T, Packer MJ, Plowright AT, Revill J, Schofield P, Sheldon C, Stokes S, Turnbull AV, Wang SJ, Whalley DP, Wood JM.: Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. Bioorg Med Chem Lett, Volume 22 (12), 2012

Authors

Addie MS, Birch AM, Birtles S, Bowker SS, Boyd S, Buckett LK, Butlin RJ, Chapman S, Davies RD, Donald CS, Green CP, Gutierrez PM, Jenner C, Kemmitt PD, Leach AG, McCoull W, Moody GC, Newcombe NJ, Nowak T, Packer MJ, Plowright AT, Revill J, Schofield P, Sheldon C, Stokes S, Turnbull AV, Wang SJ, Whalley DP, Wood JM.

Journal

Bioorg Med Chem Lett

Year

2012

DOI

10.1016/j.bmcl.2012.04.117

PubMed

22608962

Machine-readable

REST APIRDF